579 results on '"Cao, Davide"'
Search Results
52. LB-10 | Predictive Value of the Thrombotic Risk Criteria of the 2020 ESC guidelines for NSTE-ACS: Validation in a Large PCI Registry
53. New Insights into Pathophysiology and New Risk Factors for ACS
54. Procedural embolic protection strategies for carotid artery stenting: current status and future prospects
55. Impact of coronary artery disease on clinical outcomes after TAVR: Insights from the BRAVO‐3 randomized trial
56. Abstract 16790: Myocardial Injury is an Independent Predictor of Mortality in Patients With COVID-19
57. Abstract 16570: Systemic Inflammation Alters the Bleeding-Ischemic Balance in High-Bleeding Risk Patients Undergoing Percutaneous Coronary Interventions
58. Abstract 16599: Impact of Race and Ethnicity on Long Term Outcomes Post Percutaneous Coronary Intervention With Drug Eluting Stents
59. Abstract 16507: Complex Percutaneous Coronary Intervention Features Worsen Prognosis in Diabetic Patients: Insights From a Large Single-center Registry
60. Abstract 15502: Clinical Outcomes in Patients Undergoing Non-cardiac Surgery Within 1 Year of Pci
61. Predictive value of the thrombotic risk criteria proposed in the 2023 ESC guidelines for the management of ACS: insights from a large PCI registry
62. Treating Inflammation Prior to Percutaneous Coronary Intervention: Does the Heart Care?
63. Outcomes After Complex PCI With COMBO Stent Implantation: Insights from a Real-World Pooled Dataset
64. IMPACT OF SEX ON OUTCOMES AMONG PATIENTS WITH A PREVIOUS CORONARY ARTERY BYPASS GRAFT UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
65. ONE- VERSUS THREE-MONTH DAPT IN OLDER PATIENTS AT HIGH BLEEDING RISK UNDERGOING PCI: INSIGHTS FROM THE XIENCE SHORT DAPT GLOBAL PROGRAM
66. New Criteria to Identify Patients at Higher Risk for Cardiovascular Complications After Percutaneous Coronary Intervention
67. Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease
68. Ticagrelor with or without aspirin in high-risk patients with anaemia undergoing percutaneous coronary intervention: a subgroup analysis of the TWILIGHT trial
69. From surgical clamping to endovascular flow arrest/reversal: the concept behind the system
70. Biolimus-Eluting vs. Other Limus-Eluting Stents in NSTE-ACS: A Pooled Analysis of GLASSY and TWILIGHT
71. Clopidogrel Monotherapy After 1-Month DAPT in Diabetic Patients Undergoing PCI
72. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
73. Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study
74. Minding the Microcirculation: Is it Worth the Effort?
75. Clinical Outcomes and Revascularization Strategies in Patients With Low-Flow, Low-Gradient Severe Aortic Valve Stenosis According to the Assigned Treatment Modality
76. Efficacy and safety of P2Y12 inhibitor monotherapy after complex PCI: a collaborative systematic review and meta-analysis
77. 481 VITAMIN K ANTAGONISTS, DIRECT ORAL ANTICOAGULANTS, OR LEFT ATRIAL APPENDAGE CLOSURE FOR PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
78. 761 PRASUGREL OR CLOPIDOGREL IN PATIENTS WITH ACUTE CORONARY SYNDROMES AT DIFFERENT THROMBOTIC RISK: RESULTS FROM THE PROMETHEUS STUDY
79. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials
80. Ticagrelor with and without aspirin in patients with a prior coronary artery bypass graft undergoing percutaneous coronary intervention: the TWILIGHT-CABG study
81. Predictors of antiplatelet cessation in a real-world patient population undergoing non-cardiac surgery after PCI
82. Bleeding and Ischemic Outcomes With Ticagrelor Monotherapy According to Body Mass Index
83. TCT-4 Dual Antiplatelet Therapy for 1 Versus 3 Months in Women and Men at High Bleeding Risk Undergoing Drug-Eluting Stent Implantation
84. TCT-158 Pooled Analysis of Patients Undergoing Complex PCI With the Dual-Therapy COMBO Stent: The MEGA-COMBO Complex-PCI Analysis
85. TCT-13 Ticagrelor Monotherapy in Patients With Peripheral Artery Disease Undergoing PCI
86. TCT-566 Impact of Sex on Risk for Adverse Events Associated With Polyvascular Disease in Patients After PCI
87. TCT-381 Vitamin K Antagonists, Direct Oral Anticoagulants, or Left Atrial Appendage Closure for Patients With Nonvalvular Atrial Fibrillation: A Systematic Review and Network Meta-Analysis
88. ARC-HBR criteria and TAVR: not all high bleeding risk patients look alike
89. Subjective angina or myocardial ischaemia to justify PCI? Never mistake the finger for the moon
90. Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside
91. Reversal and removal of oral antithrombotic drugs in patients with active or perceived imminent bleeding.
92. Edge‐to‐edge percutaneous mitral repair for functional ischaemic and non‐ischaemic mitral regurgitation: a systematic review and meta‐analysis
93. Impact of Small Valve Size on 1-Year Outcomes After Transcatheter Aortic Valve Implantation in Women (from the WIN-TAVI Registry)
94. Antiplatelet Therapy in High-Bleeding Risk Patients Undergoing PCI: Walking a Tightrope
95. Balance of Ischemia and Bleeding in Selecting Intensity and Duration of Antithrombotic Regimens
96. A-54 | Efficacy and Safety of P2Y12 Inhibitor Monotherapy After Complex PCI: A Collaborative Systematic Review and Meta-Analysis
97. Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI
98. Rethinking the Role of Impaired Renal Function in Multivessel PCI or CABG
99. Effect of Elevated C-Reactive Protein on Outcomes After Complex Percutaneous Coronary Intervention for Angina Pectoris
100. Ticagrelor monotherapy after PCI in high-risk patients with prior MI : A prespecified TWILIGHT Substudy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.